Saccharo is a biotech start-up in the immuno-oncology space that develops products for the treatment of cancer and other novel diseases.
Saccharo has raised $7.4M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in August 2022.
Saccharo's investors include Sand Hill Angels, Life Science Angels, Xandex Investments LLP.
Saccharo is headquartered in Oakland, United States.
Saccharo is a biotech start-up in the immuno-oncology space that develops products for the treatment of cancer and other novel diseases.
Saccharo is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Saccharo — Funding & Investors." VCBacked, August 16, 2022, https://www.vcbacked.co/company/saccharo. Accessed September 30, 2026.
VCBacked. (2022). Saccharo — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/saccharo
{{cite web |title=Saccharo — Funding & Investors |url=https://www.vcbacked.co/company/saccharo |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated